Bell CD, Conen PE (1968) Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci 7:529–544. https://doi.org/10.1016/0022-510x(68)90058-0

Article  CAS  PubMed  Google Scholar 

Bettica P, Petrini S, D’Oria V, D’Amico A, Catteruccia M, Pane M, Sivo S, Magri F, Brajkovic S, Messina S et al (2016) Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul Disord 26:643–649. https://doi.org/10.1016/j.nmd.2016.07.002

Article  PubMed  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251–267. https://doi.org/10.1016/S1474-4422(18)30024-3

Article  PubMed  PubMed Central  Google Scholar 

Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T et al (2015) The TREAT-NMD DMD Global Database: analysis of more than 7000 Duchenne muscular dystrophy mutations. Hum Mutat 36:395–402. https://doi.org/10.1002/humu.22758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohm J, Barthelemy I, Landwerlin C, Blanchard-Gutton N, Relaix F, Blot S, Laporte J, Tiret L (2022) A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. https://doi.org/10.1242/dmm.049219

Article  PubMed  PubMed Central  Google Scholar 

Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K (2021) Life expectancy in duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology 97:e2304–e2314. https://doi.org/10.1212/WNL.0000000000012910

Article  PubMed  PubMed Central  Google Scholar 

Chemello F, Wang Z, Li H, McAnally JR, Liu N, Bassel-Duby R, Olson EN (2020) Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing. Proc Natl Acad Sci U S A 117:29691–29701. https://doi.org/10.1073/pnas.2018391117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desguerre I, Christov C, Mayer M, Zeller R, Becane HM, Bastuji-Garin S, Leturcq F, Chiron C, Chelly J, Gherardi RK (2009) Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS ONE 4:e4347. https://doi.org/10.1371/journal.pone.0004347

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C (2009) Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68:762–773. https://doi.org/10.1097/NEN.0b013e3181aa31c2

Article  PubMed  Google Scholar 

Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Primers 7:13. https://doi.org/10.1038/s41572-021-00248-3

Article  PubMed  PubMed Central  Google Scholar 

Dumont NA, Bentzinger CF, Sincennes MC, Rudnicki MA (2015) Satellite cells and skeletal muscle regeneration. Compr Physiol 5:1027–1059. https://doi.org/10.1002/cphy.c140068

Article  PubMed  Google Scholar 

Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, Rudnicki MA (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455–1463. https://doi.org/10.1038/nm.3990

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falzarano MS, Scotton C, Passarelli C, Ferlini A (2015) Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20:18168–18184. https://doi.org/10.3390/molecules201018168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D (2012) Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J Neurol 259:1648–1654. https://doi.org/10.1007/s00415-011-6393-2

Article  CAS  PubMed  Google Scholar 

Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G et al (2019) Cellular senescence: defining a path forward. Cell 179:813–827. https://doi.org/10.1016/j.cell.2019.10.005

Article  CAS  PubMed  Google Scholar 

Huang S, Bhattacharya A, Ghelfi MD, Li H, Fritsch C, Chenoweth DM, Goldman YE, Cooperman BS (2022) Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination. Nat Commun 13:2413. https://doi.org/10.1038/s41467-022-30080-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kharraz Y, Guerra J, Pessina P, Serrano AL, Munoz-Canoves P (2014) Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed Res Int 2014:965631. https://doi.org/10.1155/2014/965631

Article  PubMed  PubMed Central  Google Scholar 

Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H et al (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45:498–506

CAS  PubMed  PubMed Central  Google Scholar 

Kudlova N, De Sanctis JB, Hajduch M (2022) Cellular senescence: molecular targets, biomarkers, and senolytic drugs. Int J Mol Sci. https://doi.org/10.3390/ijms23084168

Article  PubMed  PubMed Central  Google Scholar 

Lemos DR, Babaeijandaghi F, Low M, Chang CK, Lee ST, Fiore D, Zhang RH, Natarajan A, Nedospasov SA, Rossi FM (2015) Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat Med 21:786–794. https://doi.org/10.1038/nm.3869

Article  CAS  PubMed  Google Scholar 

Lim KR, Maruyama R, Yokota T (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther 11:533–545. https://doi.org/10.2147/DDDT.S97635

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malfatti E, Romero NB (2017) Diseases of the skeletal muscle. Handb Clin Neurol 145:429–451. https://doi.org/10.1016/B978-0-12-802395-2.00030-4

Article  PubMed  Google Scholar 

McDonald CM, Marden JR, Shieh PB, Wong BL, Lane H, Zhang A, Nguyen H, Frean M, Trifillis P, Koladicz K et al (2023) Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status. J Comp Eff Res 12:e220190. https://doi.org/10.57264/cer-2022-0190

Article  PubMed  PubMed Central  Google Scholar 

McDonald CM, Muntoni F, Penematsa V, Jiang J, Kristensen A, Bibbiani F, Goodwin E, Gordish-Dressman H, Morgenroth L, Werner C et al (2022) Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients. J Comp Eff Res 11:139–155. https://doi.org/10.2217/cer-2021-0196

Article  CAS  PubMed  Google Scholar 

McDonald CM, Shieh PB, Abdel-Hamid HZ, Connolly AM, Ciafaloni E, Wagner KR, Goemans N, Mercuri E, Khan N, Koenig E et al (2021) Open-label evaluation of eteplirsen in patients with duchenne muscular dystrophy amenable to exon 51 skipping: PROMOVI trial. J Neuromuscul Dis 8:989–1001. https://doi.org/10.3233/JND-210643

Article  PubMed  PubMed Central  Google Scholar 

Mendell JR, Rodino-Klapac LR, Sahenk Z, Roush K, Bird L, Lowes LP, Alfano L, Gomez AM, Lewis S, Kota J et al (2013) Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol 74:637–647. https://doi.org/10.1002/ana.23982

Article  CAS  PubMed  Google Scholar 

Moiseeva V, Cisneros A, Sica V, Deryagin O, Lai Y, Jung S, Andres E, An J, Segales J, Ortet L et al (2023) Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature 613:169–178. https://doi.org/10.1038/s41586-022-05535-x

Article  CAS  PubMed  Google Scholar 

Moratal C, Arrighi N, Dechesne CA, Dani C (2019) Control of muscle fibro-adipogenic progenitors by myogenic lineage is altered in aging and duchenne muscular dystrophy. Cell Physiol Biochem 53:1029–1045. https://doi.org/10.33594/000000196

Article  CAS  PubMed  Google Scholar 

Peverelli L, Testolin S, Villa L, D’Amico A, Petrini S, Favero C, Magri F, Morandi L, Mora M, Mongini T et al (2015) Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy. Neurology 85:1886–1893. https://doi.org/10.1212/WNL.0000000000002147

Article  CAS  PubMed  PubMed Central  Google Scholar 

Relaix F, Bencze M, Borok MJ, Der Vartanian A, Gattazzo F, Mademtzoglou D, Perez-Diaz S, Prola A, Reyes-Fernandez PC, Rotini A et al (2021) Perspectives on skeletal muscle stem cells. Nat Commun 12:692. https://doi.org/10.1038/s41467-020-20760-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, Wakefield LM, Woodcock J (2015) Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med 7:299rv294. https://doi.org/10.1126/scitranslmed.aaa73223

Article  Google Scholar